Newly launched Synchron says it will leverage a novel technology for implanting a neural-recording device in the brain on its mission to develop the world's first endovascular neural interface to power robotic limbs.
The Silicon Valley-headquartered company announced its existence April 21 with a seasoned neurovascular device industry veteran, Martin Dieck, as its chairman. Dieck was most recent co-founder and CEO of intravascular...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?